India’s growing demand for GLP-1 weight-loss drugs has triggered a surge of misleading products on e-commerce platforms, raising safety concerns. Popular medicines like Ozempic and Mounjaro have gained attention, but regulators warn against unauthorised sales and promotions. Authorities are tightening checks to prevent misuse and protect consumers.
Telangana
GLP-1 Trend Raises Concerns Over Fake Products
